Irving J, Jesson J, Virgo P, Case M, Minto L, Eyre L et al (2009) Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-centre setting. Haematologica. 94:870–874
Article
Google Scholar
Cheng SH, Lau KM, Li CK, Chan NPH, Ip RKL, Cheng CK et al (2013) Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction. Plos One. 8(7):e69467
Article
CAS
Google Scholar
Schrappe M (2012) Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient. Hematology Am Soc Hematol Educ Program. 2012:137–142. https://doi.org/10.1182/asheducation-2012.1.137
Article
Google Scholar
Moorman A, Chilton L, Wilkinson J (2010) A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood. 115:206–214
Article
CAS
Google Scholar
Kager L, Lion T, Attarbaschi A, Koeing M, Strehl S, Haas O (2007) Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children. Haematologica. 92(11):1561–1564
Article
Google Scholar
Pieters R, Carroll W (2008) Biology and treatment of acute lymphoblastic leukemia. Pediatr. Clin. North. Am. 55(1):1–20
Article
Google Scholar
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J et al (2008) In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, France
Google Scholar
Campbell L (2006) Cytogenetic and FISH techniques in myeloid malignancies. Methods Mol Med. 125:13–28
Google Scholar
Hastings R, Howell R, Betts D, Porter S, Haferlach C, Dastugue N, et al. Guidelines and quality assurance for acquired cytogenetics a common European framework for quality assessment for banded chromosome studies and molecular cytogenetic investigations of acquired abnormalities. European Cytogenetics Association Newsletter. 2013; No 13.
Borowitz M, Devidas M, Hunger S, Bowman W, Carroll A, Carroll W (2008) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children’s Oncology Group study. Blood. 111(12):5477–5485
Article
CAS
Google Scholar
Campana D, and Pui C. Childhood acute lymphoblastic leukemia. In: Postgraduate haematology [Hoffbrand AV, Catovsky D, Tuddenham EGD and Green AR (eds.)], 6th Edition, Chapter 25; P: 448-462, Wiley-BlackWell, UK.
Matloub Y, Angiolillo A, Bostrom B, Hunger SP, Gaynon P, Carroll W et al (2006) Double delayed intensification (DDI) is equivalent to single DI (SDI) in children with National Cancer Institute (NCI) standard-risk acute lymphoblastic leukemia (SR-ALL) treated on Children’s Cancer Group (CCG) clinical trial 1991 (CCG-1991). Blood 108(11):47A–48A Meeting abstract:146
Article
Google Scholar
Seibel NL, Steinherz PG, Sather HN, Nachman JB, Delaat C, Ettinger LJ et al (2008) Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood 1:111(5):2548–2555
Article
Google Scholar
Schultz K, Pullen D, Sather H, Shuster J, Devidas M, Borowitz M et al (2007) Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG). Blood. 109(3):926–934
Article
CAS
Google Scholar
Siddaiahgar S, Awagbad S, Latha M (2015) Clinical, Immunophenotype and cytogenetic profile in children at tertiary health care centre in India. Muller J Med Sci Res 6:112–118
Article
Google Scholar
Rowe J (2010) Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol 150:389–340
Google Scholar
Pui C, Pei D, Campana D, Cheng C, Sandlund J, Bowman W et al (2014) A revised definition for the cure of childhood acute lymphoblastic leukemia. Leukemia 28:2336–2343
Article
CAS
Google Scholar
Borowitz M, Wood B, Devidas M, Loh M, Raetz E, Salzer W et al (2015) Prognostic significance of minimal residual disease in high-risk B-ALL: a report from Children’s Oncology Group study AALL0232. Blood. 126(8):964–971
Article
CAS
Google Scholar
Rocha J, Xavier S, Souza M, Assumpção J, Murao M, de Oliveira B (2016) Current strategies for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Mediterr J Hematol Infect Dis 8(1):e2016024. https://doi.org/10.4084/MJHID.2016.024
Article
PubMed Central
Google Scholar
Coustan-Smith E, Song G, Clark C, Key L, Liu P, Mehrpooya M et al (2011) New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 117(23):6267–6276
Article
CAS
Google Scholar
Al-Kzayer L, Sakashita K, Matsuda K, Al-Hadad S, Al-Jadiry M, Abed W et al (2012) Genetic evaluation of childhood acute lymphoblastic leukemia in Iraq using FTA cards. Pediatric Blood Cancer. 3(1):1–7
Google Scholar
Jeha S, Coustan-Smith E, Pei D, Sandlund J, Rubnitz J, Howard S et al (2014) Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer. 120:1514–1519
Article
CAS
Google Scholar
Terwilliger T, Abdul-Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7:e577–e589
Article
CAS
Google Scholar
Möricke A, Lauten M, Beier R, Odenwald E, Stanulla M, Zimmermann M et al (2013) Prediction of outcome by early response in childhood acute lymphoblastic leukemia. Klin Padiatr. 225(Suppl. 1):S50–S56
Google Scholar
Harvey R, Mullighan C, Wang X (2010) Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 116(23):4874–4884
Article
CAS
Google Scholar
Cooper S, Brown P (2015) Treatment of pediatric acute lymphoblastic leukemia. Pediatr. Clin. North. Am 62(1):61–73
Article
Google Scholar
Juárez-Velázquez M, Salas-Labadía C, Reyes-León A, Navarrete-Meneses M, Fuentes-Pananá E, Pérez-Vera P. Genetic markers in the prognosis of childhood acute lymphoblastic leukemia. In: Clinical epidemiology of acute lymphoblastic leukemia - from the molecules to the clinic.2013; 3:193-235. https://doi.org/10.5772/54288.
Fielding A (2010) How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 116(18):3409–3417
Article
CAS
Google Scholar
Shiozawa Y, Pedersen E, Taichman R (2010) GAS6/ Mer axis regulate the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche. Experimental Hematology. 38:132–140
Article
CAS
Google Scholar
Pui C, Pei D, Raimondi S, Coustan-Smith E, Jeha S, Cheng C et al (2017) Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with response-adapted therapy. Leukemia. 31(2):333–339
Article
Google Scholar
Woo J, Alberti M, Tirado C (2014) Childhood B-acute lymphoblastic leukemia: a genetic update. Exp Hematol Oncol 3(16):1–14
Google Scholar
Orbo N, Ryder L, Madsen H, Andersen M, Lausen B, Hasle H et al (2012) Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods. Haematologica. 97:137–141
Article
Google Scholar
Tamai H, Inokuchi K (2010) 11q23/MLL acute leukemia: update of clinical aspects. J Clin Exp Hematol. 50(2):91–98
Article
Google Scholar
Monika Bruggemann M, Raff T, Kneba M (2012) Has MRD monitoring superseded other prognostic factors in adult ALL? Blood. 120(23):4470–4481
Article
Google Scholar
Vora A, Goulden N, Wade R (2013) Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): A randomized controlled trial. Lancet Oncol. 14:199–209
Article
CAS
Google Scholar
Basso G, Veltroni M, Valsecchi M, Dworzak M, Ratei R, Silvestri D et al (2009) Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J Clin Oncol. 27(31):5168–5174
Article
Google Scholar